Twice-Weekly Dialysis May Preserve Residual Kidney Function
Patients with preserved residual kidney function experience a survival benefit.
Print Issue: March 01, 2016
Parathyroidectomy Cuts Mortality Risk in Patients With Severe SHPT
Study finds a 20% to 25% lower risk for early death over the long term.
Prostate Cancer Diagnosis Ups Risk of Non-Cancer Hospitalizations
Risk of being admitted for non-cancer conditions is 38% higher in the year after a PCa diagnosis compared with a year before.
Study Supports Hemiablation HIFU for Prostate Cancer
Ablating only the prostate lobe with the tumor resulted in satisfactory mid-term functional outcomes, researchers reported.
Recommendations Issued for Tolvaptan Use in ADPKD
ERA-EDTA offers guidance on selecting patients for treatment, when to start the drug, dosing strategies, and other aspects of care.
Polycystic Kidney Disease Raises Atrial Fibrillation Risk
In a study, the arrhythmia was 31% more likely to occur in PKD patients than non-PKD control patients.
Study: Sleep Apnea May Be a CKD Risk Factor
Chronic kidney disease found to be 58% more likely to develop in individuals with than without the sleep disorder.
Tolvaptan Lowers ADPKD Albuminuria
New findings suggest the medication induces beneficial renal structural changes.
ESRD Anemia Responds to Investigational Oral Drug
In a phase 2 trial, roxadustat maintained hemoglobin levels over 19 weeks as well as epoetin alfa.
Simpler Prostate Cancer Grading System Proposed
Tumors fall into 1 of 5 grade groups based on what pathologic findings indicate about prognosis.
Next post in Prostate Cancer
